{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:01:41Z","timestamp":1793138501270,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Plan of China","doi-asserted-by":"publisher","award":["2016YFC1306700"],"award-info":[{"award-number":["2016YFC1306700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012230","name":"Science and Technology Program of Guangdong","doi-asserted-by":"publisher","award":["2018B030334001"],"award-info":[{"award-number":["2018B030334001"]}],"id":[{"id":"10.13039\/501100012230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005063","name":"Program of Excellent Talents","doi-asserted-by":"publisher","award":["JCRCA2016006"],"award-info":[{"award-number":["JCRCA2016006"]}],"id":[{"id":"10.13039\/501100005063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.euroneuro.2020.09.633","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T13:00:37Z","timestamp":1600952437000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"41","author":[{"given":"Yachen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.euroneuro.2020.09.633_bib0001","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv103","article-title":"S100B serum levels predict treatment response in patients with melancholic depression","volume":"19","author":"Ambree","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2020.09.633_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.euroneuro.2020.09.633_bib62","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.euroneuro.2014.03.006","article-title":"BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial","volume":"24","author":"Brunoni","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"e677","key":"10.1016\/j.euroneuro.2020.09.633_bib0003","article-title":"Increased serum levels of sortilin are associated with depression and correlated with BDNF and VEGF","volume":"5","author":"Buttenschon","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2020.09.633_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00213-010-2129-8","article-title":"Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine","volume":"215","author":"Calabrese","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0005","first-page":"6218","article-title":"Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis","author":"Carvalho","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"Pt B","key":"10.1016\/j.euroneuro.2020.09.633_bib0006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","article-title":"Brain-derived neurotrophic factor in mood disorders and antidepressant treatments","volume":"97","author":"Castren","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"134618","key":"10.1016\/j.euroneuro.2020.09.633_bib0007","article-title":"Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia","volume":"714","author":"Chen","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0008","first-page":"69556","article-title":"TNFalpha disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice","author":"Cheng","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.euroneuro.2020.09.633_bib0009","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/15622975.2015.1117655","article-title":"Vascular endothelial growth factor: potential predictor of treatment response in major depression","volume":"18","author":"Clark-Raymond","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2020.09.633_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"issue":"e608111","key":"10.1016\/j.euroneuro.2020.09.633_bib0011","article-title":"Evaluation of serum glial cell line-derived neurotrophic factor in Bangladeshi major depressive disorder patients","volume":"11","author":"Das","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0012","first-page":"220103","article-title":"Trk receptors","author":"Deinhardt","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1601","key":"10.1016\/j.euroneuro.2020.09.633_bib0013","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1098\/rstb.2011.0357","article-title":"A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists.","volume":"367","author":"Duman","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.euroneuro.2020.09.633_bib0014","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.euroneuro.2020.09.633_bib0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cns.12517","article-title":"Increased plasma S100beta level in patients with major depressive disorder","volume":"22","author":"Fang","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.euroneuro.2020.09.633_bib0016","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jad.2013.06.055","article-title":"VEGF plasma level variations in duloxetine-treated patients with major depression","volume":"151","author":"Fornaro","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.euroneuro.2020.09.633_bib0017","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"149","key":"10.1016\/j.euroneuro.2020.09.633_bib0018","article-title":"Exploration of 27 plasma immune markers: a cross-sectional comparison of 64 old psychiatric inpatients having unipolar major depression and 18 non-depressed old persons","volume":"18","author":"Gaarden","year":"2018","journal-title":"BMC Geriatr."},{"issue":"3","key":"10.1016\/j.euroneuro.2020.09.633_bib0019","first-page":"280","article-title":"Suggested biomarkers for major depressive disorder","volume":"55","author":"Hacimusalar","year":"2018","journal-title":"Noro Psikiyatr. Ars."},{"issue":"3","key":"10.1016\/j.euroneuro.2020.09.633_bib0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2012.09.006","article-title":"Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study","volume":"144","author":"Halmai","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0021","first-page":"343d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.euroneuro.2020.09.633_bib0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.euroneuro.2020.09.633_bib0023","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4306\/pi.2008.5.3.193","article-title":"Serum S100B levels and major depressive disorder: its characteristics and role in antidepressant response","volume":"5","author":"Jang","year":"2008","journal-title":"Psychiatry Investig."},{"issue":"9","key":"10.1016\/j.euroneuro.2020.09.633_bib0024","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biopsych.2005.01.008","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity","volume":"57","author":"Karege","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"e1065","key":"10.1016\/j.euroneuro.2020.09.633_bib0025","article-title":"Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0026","first-page":"8308","article-title":"Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses","author":"Kishi","year":"2017","journal-title":"Front. Psychiatr"},{"issue":"6","key":"10.1016\/j.euroneuro.2020.09.633_bib0027","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.euroneuro.2014.12.013","article-title":"IGF-I in major depression and antidepressant treatment response","volume":"25","author":"Kopczak","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2020.09.633_bib0028","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/08039488.2018.1472295","article-title":"Does S100B have a potential role in affective disorders? A literature review","volume":"72","author":"Kroksmark","year":"2018","journal-title":"Nord. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2020.09.633_bib0029","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","article-title":"Vascular endothelial growth factor: a neurovascular target in neurological diseases","volume":"12","author":"Lange","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.euroneuro.2020.09.633_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/neu.2015.42","article-title":"Plasma glial cell line-derived neurotrophic factor in patients with major depressive disorder: a preliminary study","volume":"28","author":"Lee","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0031","first-page":"339b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.euroneuro.2020.09.633_bib0032","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00018-013-1280-x","article-title":"Delineating multiple functions of VEGF-A in the adult brain","volume":"70","author":"Licht","year":"2013","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0033","first-page":"6320","article-title":"Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study","author":"Lin","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2020.09.633_bib0034","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0035","first-page":"1445","article-title":"Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments","author":"Lo","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.101983","article-title":"Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: a systematic review and meta-analysis","author":"Luan","year":"2020","journal-title":"Asian J. Psychiatr."},{"issue":"9","key":"10.1016\/j.euroneuro.2020.09.633_bib0037","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.psyneuen.2013.02.009","article-title":"NGF serum levels variations in major depressed patients receiving duloxetine","volume":"38","author":"Martino","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.euroneuro.2020.09.633_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2011.05.005","article-title":"Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action","volume":"46","author":"Nowacka","year":"2012","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.euroneuro.2020.09.633_bib0039","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pharep.2016.04.003","article-title":"Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity","volume":"68","author":"Oglodek","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.euroneuro.2020.09.633_bib0041","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2020.09.633_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jad.2007.05.005","article-title":"Plasma and serum brain-derived neurotrophic factor depressed patients during 1 year of antidepressant (BDNF) in treatments.","volume":"105","author":"Piccinni","year":"2008","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.euroneuro.2020.09.633_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061189","article-title":"Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations","volume":"18","author":"Polyakova","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0043","first-page":"174432","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0044","first-page":"8639","article-title":"Peripheral blood nerve growth factor levels in major psychiatric disorders","author":"Rao","year":"2017","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.euroneuro.2020.09.633_bib0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/jemt.10303","article-title":"S100B in brain damage and neurodegeneration","volume":"60","author":"Rothermundt","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"8","key":"10.1016\/j.euroneuro.2020.09.633_bib0046","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00406-018-0919-x","article-title":"Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy","volume":"268","author":"Ryan","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2020.09.633_bib0047","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0968-0004(96)80167-8","article-title":"The S100 family of EF-hand calcium-binding proteins: functions and pathology","volume":"21","author":"Sch\u00e4fer","year":"1996","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.euroneuro.2020.09.633_bib0048","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5498\/wjp.v2.i3.49","article-title":"Neuroplasticity and major depression, the role of modern antidepressant drugs","volume":"2","author":"Serafini","year":"2012","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.euroneuro.2020.09.633_bib0050","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0051","first-page":"82","article-title":"Evidence for a wide extra-astrocytic distribution of S100B in human brain","author":"Steiner","year":"2007","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0052","first-page":"245602","article-title":"Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity","author":"Sun","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.euroneuro.2020.09.633_bib0053","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2012.12020248","article-title":"Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder","volume":"169","author":"Tripp","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2020.09.633_bib0054","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0306-9877(03)00299-8","article-title":"Down-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression","volume":"62","author":"Tsai","year":"2004","journal-title":"Med. Hypotheses"},{"issue":"10","key":"10.1016\/j.euroneuro.2020.09.633_bib0055","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.euroneuro.2015.06.001","article-title":"Increased levels of vascular endothelial growth factor in patients with major depressive disorder: a meta-analysis","volume":"25","author":"Tseng","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2020.09.633_bib0056","doi-asserted-by":"crossref","first-page":"e2411","DOI":"10.1097\/MD.0000000000002411","article-title":"Significantly higher peripheral insulin-like growth factor-1 levels in patients with major depressive disorder or bipolar disorder than in healthy controls: a meta-analysis and review under guideline of PRISMA","volume":"95","author":"Tu","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.euroneuro.2020.09.633_bib0057","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/pcn.12621","article-title":"Epigenetic mechanisms of major depression: targeting neuronal plasticity","volume":"72","author":"Uchida","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2020.09.633_bib0058","first-page":"241514","article-title":"Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression","author":"Wilkinson","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"2-3","key":"10.1016\/j.euroneuro.2020.09.633_bib0059","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.psychres.2009.01.011","article-title":"Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression","volume":"170","author":"Zhang","year":"2009","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2020.09.633_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172270","article-title":"Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20302625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X20302625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:58:28Z","timestamp":1760378308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X20302625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":62,"alternative-id":["S0924977X20302625"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.09.633","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2020.09.633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}